🇺🇸 FDA

Intelligence Platform

Patents

Browse 3,063 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 6696562

Avian astrovirus

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Feb 24 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6696064

Methods of protecting vasculature from damage by diphtheria toxin-and pseudomonas toxin-ba

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 24 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6689383

Chromium-histidine complexes as nutrient supplements

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Feb 10 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6689560

Raf protein kinase therapeutics

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 10 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6689367

Production of attenuated chimeric respiratory syncytial virus vaccines from cloned nucleot

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 10 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6685944

Modified HCV peptide vaccines

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 03 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6686333

Inhibition of HIV replication using soluble Tat peptide analogs

The United States of America as represented by the Department of Health and Human Resources · Granted Tue Feb 03 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6685949

Lipooligosaccharide based vaccine for prevention of moraxella (branhamella)catarrhalis inf

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 03 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6685948

Replication-defective dengue viruses that are replication-defective in mosquitoes for use

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 03 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6685933

Interferon &agr; hybrids

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 03 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6682741

&bgr;2 microglobulin fusion proteins and high affinity variants

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jan 27 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 22 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6682758

Water-insoluble drug delivery system

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jan 27 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 22 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6682728

Efficient and selective adenoviral-mediated gene transfer into vascular neointima

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jan 27 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 22 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6680060

Hepatitus A virus vaccines

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jan 20 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 15 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6680176

Identification of candidate ligands which modulate antigen presenting cells

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jan 20 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 15 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6680374

Invaplex from gram negative bacteria, method of purification and methods of use

The United States of America as represented by the Secretary of the Army · Granted Tue Jan 20 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 15 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6676973

Method of treating ovarian cancers with cadmium

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jan 13 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 08 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6676936

Chimeric and/or growth-restricted flaviviruses

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jan 13 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 08 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6673905

Conjugation of biomolecules using Diels-Alder cycloaddition

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jan 06 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6673559

Met proto-oncogene and a method for predicting breast cancer progression

The United States of America as Represented by the Government of the Department of Health and Human Services · Granted Tue Jan 06 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6673342

Recombinant human IgA-J chain dimer

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jan 06 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6670374

Swainsonine compounds as inhibitors of toxin receptor expression

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Dec 30 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 25 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6669962

Starch microcapsules for delivery of active agents

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Dec 30 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 25 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6669935

Delivery of therapeutic agents by gene therapy

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Dec 30 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 25 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired